COLO-SW-1 Pivotal Clinical Investigation

Status Completed

Clinical Trial Summary

The Clinical Investigation is a summative usability study and a 'first-in-patient'-study of the independent medical device software (MDSW) utilizing artificial intelligence. The MDSW has completed the development phase and is ready to enter production. The primary objective of this study is to assess the user safety and secondary the user-friendliness of the MDSW to confirm compliance to certain General safety and performance requirements (GSPR) set by the MDR. The software to assess will be installed in a medical grade PC to allow the use of the MDSW according to its intended purpose of detecting colorectal polyps. However, the PC is not a part of the medical device under investigation and its performance and safety will not be assessed by this investigation. The intended purpose and clinical benefit of the MDSW is to assist the endoscopist in detecting more polyps, with the possibility of subsequently preventing colorectal cancer later on. The data obtained from the investigation will be used for regulatory purposes aiming to obtain a CE certification as class IIa according to MDR for the MDSW under investigation. The multi-center investigation will assess 8-20 endoscopists experience with the MDSW and whether technical difficulties occur during its use in one site. The user experience of the endoscopists will be collected in a questionnaire form. The investigator will additionally record any possible adverse effects (AE) or adverse technical effects (ATE) of the use of the MDSW. The MDSW will be used during ordinary colonoscopy in adult, out-patients ≥18 years but variables related to the patient outcome will not be assessed. Patients with inadequate bowel preparation, active inflammation, cecum not reached or not consenting will be excluded from the study. Each endoscopist will assess the device during 3-5 patient examinations. The primary objective of the investigation is to confirm that COLO-SW-1 is safe for use during colonoscopy as intended for aiding in detection of polyps. The secondary objective is to assess the user-friendliness of the MDSW interface. The clinical investigation is estimated to start in August 2022. The participation of the endoscopists will take place continuously through the clinical investigation until required number (up to 20) of participants has been reached. When 8 participants have been included in total, an interim analysis is made, and the Principal Investigator decides if the confirmatory objectives have been met. A conclusion can be drawn from the partial objectives met at this point. The study can continue for up to 20 participants to complete all endpoints, if required. The investigation will be closed by end of October 2022. The investigation will be deemed completed once the last evaluation form has been completed by the endoscopists.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05519098
Study type	Observational
Source	Augere Medical AS
Contact
Status	Completed
Phase
Start date	August 23, 2022
Completion date	October 26, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04101097` - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed	`NCT03247595` - Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy	N/A
Completed	`NCT04214301` - An Open-Label Preference Evaluation of BLI800	Phase 4
Withdrawn	`NCT05754255` - Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center	N/A
Recruiting	`NCT02484105` - Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction	Phase 4
Active, not recruiting	`NCT02264249` - Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation	N/A
Terminated	`NCT01978509` - The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies	N/A
Completed	`NCT01964417` - The Comparative Study Between Bowel Preparation Method	Phase 3
Recruiting	`NCT01685970` - Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy	Phase 3
Completed	`NCT01518790` - Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children	N/A
Recruiting	`NCT00748293` - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet	N/A
Completed	`NCT00779649` - MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial	Phase 4
Completed	`NCT00671177` - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique	N/A
Completed	`NCT00380497` - Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children	Phase 4
Recruiting	`NCT00160823` - Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients	Phase 3
Completed	`NCT00314418` - Patient Position and Impact on Colonoscopy Time	N/A
Completed	`NCT00390598` - PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy	Phase 2/Phase 3
Completed	`NCT00427089` - Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening	Phase 3
Completed	`NCT00209573` - A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy	Phase 3
Completed	`NCT05823350` - The Effect of Abdominal Massage on Pain and Distention After Colonoscopy	N/A